HeartFlow Analysis vs ClearRead CT
AI Verdict
Choose HeartFlow Analysis if…
Choose HeartFlow Analysis if your primary goal is a comprehensive, non-invasive functional assessment of coronary artery disease, including the impact of stenosis on blood flow (FFRct) and detailed plaque characterization. This tool is ideal for guiding treatment decisions and risk stratification by providing personalized 3D models and computational fluid dynamics insights.
View HeartFlow Analysis →Choose ClearRead CT if…
Choose ClearRead CT if your focus is on significantly improving the detection and characterization of pulmonary nodules, including automated tracking over time, and efficiently performing coronary artery calcification scoring from standard CT scans. This solution is particularly well-suited for radiologists seeking to enhance diagnostic accuracy and reduce reading times in cardiothoracic imaging workflows.
View ClearRead CT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HeartFlow Analysis | ClearRead CT |
|---|---|---|
| Pricing | Contact vendor for pricing | Contact for pricing |
| Deployment | Cloud-based (AWS) | On-premise (stand-alone server, virtual machine) and Cloud |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ClearRead CTClearRead CT emphasizes seamless PACS integration and concurrent reading, allowing radiologists to stay within their existing workflow and view AI results alongside original images, which is a significant usability advantage. HeartFlow Analysis, while providing a personalized 3D model via a secure web interface, requires sending CCTA images to HeartFlow for analysis, which might introduce an extra step in the workflow.
Clinical Value
HeartFlow AnalysisHeartFlow Analysis offers a comprehensive solution for diagnosing and managing coronary artery disease by providing AI-powered 3D models, FFRct analysis, and plaque analysis, which has been shown to change management decisions in a significant percentage of cases and reduce unnecessary invasive procedures. ClearRead CT focuses on pulmonary nodule detection and coronary artery calcification scoring, improving accuracy and reducing reading times for these specific applications. While both offer significant clinical value, HeartFlow's ability to non-invasively assess the functional significance of coronary blockages and guide treatment decisions gives it a slight edge in overall clinical impact for its specific domain.
Pricing & Value
HeartFlow AnalysisHeartFlow Analysis has established Category I CPT codes for FFRct Analysis and AI-Enabled Quantitative Plaque Analysis, and is covered by Medicare and most U.S. commercial payers, with national payment rates established by CMS. This transparency and broad reimbursement coverage offer a clear value proposition. ClearRead CT's pricing is contact-vendor-based, and while some VA order ranges are available, there's no published price list, making direct cost-benefit analysis more challenging for potential users.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness. HeartFlow has been adopted by over 1,800 institutions and emphasizes seamless clinical integration with existing IT solutions like PACS and EMR. ClearRead CT is designed for universal PACS interoperability, is used in 15 countries, processes over 4 million annual exams, and offers both on-premise and cloud deployment options. Both appear capable of large-scale deployment and integration within healthcare systems.
Innovation
HeartFlow AnalysisHeartFlow Analysis pioneered the non-invasive FFRct analysis using computational fluid dynamics to simulate blood flow, providing functional assessment of coronary artery disease that traditionally required invasive procedures. This represents a significant innovation in cardiac diagnostics. ClearRead CT's vessel suppression technology and AI-powered nodule detection are innovative for improving diagnostic accuracy and workflow efficiency in cardiothoracic imaging, but HeartFlow's core technology addresses a more fundamental shift from invasive to non-invasive functional assessment.
Support & Docs
HeartFlow AnalysisHeartFlow provides comprehensive support including hands-on training, technology integration, expert coding support, peer mentorship, and educational/marketing materials. They also offer a full clinical field and technical support team. ClearRead CT offers customer care via email and phone, a support ticket system, FAQs, and manuals, but some publicly available technical documentation may be limited.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HeartFlow Analysis | ClearRead CT |
|---|---|---|
| Company | HeartFlow | RIVERAIN TECHNOLOGIES |
| Primary Diagnostic Focus | Diagnosing and managing coronary artery disease (CAD) via non-invasive 3D models and FFRct. | Enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. |
| Key AI Feature: Coronary Analysis | AI-powered 3D modeling of coronary arteries, Fractional Flow Reserve derived from CT (FFRct) analysis, Plaque Analysis (quantification and characterization). | Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs). |
| Key AI Feature: Pulmonary/Nodule Analysis | Not specified | Pulmonary Nodule Detection (solid, part-solid, ground glass), Nodule Characterization and Measurement, Automated Nodule Tracking and Comparison to Prior Exams, Patented Vessel Suppression. |
| Specialties Supported | Cardiology, Radiology | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring HeartFlow Analysis and ClearRead CT.